In today’s fast-paced world, respiratory issues have become increasingly common, affecting individuals of all ages. Whether it’s due to environmental pollutants, allergens, or chronic conditions like ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.8 billion, has been navigating a complex ...

Medicare Part D and Medicare Advantage (Part C) plans with drug coverage typically cover inhalers for COPD. But you may still ... of any insurance or insurance products. Healthline Media does ...

We recently published a list of 10 Best Stocks to Buy and Hold For 2025. In this article, we are going to take a look at ...

Cannabis dabbing, an increasingly popular way to consume highly concentrated THC, has been linked to pulmonary and neurologic ...

In a report released on January 24, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research ...

Dozens of health studies through the years have revealed the negative impact smoking can have on our bodies. But is that the ...

DMedical Ltd (ASX:4DX) has signed a major commercial contract with Queensland-based diagnostic imaging services provider Qscan Radiology Clinics relating to the former’s lung health assessment ...

As wildfires continue to affect communities across California, people not only need to remain vigilant about the threat of ...

for COPD - as has China's National Medical Products Administration (NMPA), which announced its approval the same day. It's the first ever biologic medicine for COPD in either country. Specifically ...

At Arab Health 2025, Myant will showcase its mission to enable human-centric, precise, and preventive care through continuous ...